Prospects of IL-2 in Cancer Immunotherapy
- PMID: 29854806
- PMCID: PMC5960517
- DOI: 10.1155/2018/9056173
Prospects of IL-2 in Cancer Immunotherapy
Abstract
IL-2 is a powerful immune growth factor and it plays important role in sustaining T cell response. The potential of IL-2 in expanding T cells without loss of functionality has led to its early use in cancer immunotherapy. IL-2 has been reported to induce complete and durable regressions in cancer patients but immune related adverse effects have been reported (irAE). The present review discusses the prospects of IL-2 in immunotherapy for cancer.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
